preclinics logotype
News item

SARS-CoV-2 and COVID-19 research

preclinics is developing assays for SARS-CoV-2 and COVID-19 research. Now our virus neutralizing assays are available to test the neutralizing effect of antibodies and sera. Assays for protease inhibitors, as well as in vivo models in K18-huACE2 mice will follow soon. For covid19 research we have a lung inflammation model established.


Serum of alpaca Tyson neutralize psv.SARS-CoV-2 infection